These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1499 related items for PubMed ID: 17118313

  • 1. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP.
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [Abstract] [Full Text] [Related]

  • 2. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L, Tanderup K, Nielsen SK, Christensen HK, Røhl L, Pedersen EM, Schønemann NK, Lindegaard JC.
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [Abstract] [Full Text] [Related]

  • 3. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C.
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [Abstract] [Full Text] [Related]

  • 4. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
    Nag S, Martínez-Monge R, Copeland LJ, Vacarello L, Lewandowski GS.
    Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ, Huang EY, Sun LM, Chen HC, Fang FM, Hsu HC, Changchien CC, Leung SW.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):179-89. PubMed ID: 15093915
    [Abstract] [Full Text] [Related]

  • 7. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S.
    Brachytherapy; 2008 May 01; 7(4):336-42. PubMed ID: 18782683
    [Abstract] [Full Text] [Related]

  • 8. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer.
    Beriwal S, Rwigema JC, Higgins E, Kim H, Houser C, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC.
    Brachytherapy; 2012 May 01; 11(3):176-80. PubMed ID: 21665553
    [Abstract] [Full Text] [Related]

  • 9. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.
    Pai HH, Souhami L, Clark BG, Roman T.
    Gynecol Oncol; 1997 Aug 01; 66(2):300-7. PubMed ID: 9264580
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 11. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
    Kasibhatla M, Clough RW, Montana GS, Oleson JR, Light K, Steffey BA, Jones EL.
    Int J Radiat Oncol Biol Phys; 2006 Jun 01; 65(2):398-403. PubMed ID: 16542793
    [Abstract] [Full Text] [Related]

  • 12. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C, Magné N, Dumas I, Messai T, Vicenzi L, Gillion N, Morice P, Haie-Meder C.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):133-9. PubMed ID: 18774656
    [Abstract] [Full Text] [Related]

  • 13. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar 01; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 14. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD, Rai B, Mallick I, Sharma SC.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):125-30. PubMed ID: 15850912
    [Abstract] [Full Text] [Related]

  • 15. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
    Agrawal PP, Singhal SS, Neema JP, Suryanarayan UK, Vyas RK, Rathi AK, Bahadur AK.
    Gynecol Oncol; 2005 Oct 01; 99(1):169-75. PubMed ID: 16081150
    [Abstract] [Full Text] [Related]

  • 16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 17. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R, Hayashi K, Ayukawa F, Toda K, Iwata M, Oota S, Hoshi A, Wakatsuki M, Kurosaki H, Okazaki A, Shibuya H.
    Brachytherapy; 2008 Oct 01; 7(3):260-6. PubMed ID: 18579445
    [Abstract] [Full Text] [Related]

  • 18. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e49-56. PubMed ID: 21470794
    [Abstract] [Full Text] [Related]

  • 19. Improved treatment planning for the Syed-Neblett template using endorectal-coil magnetic resonance and intraoperative (laparotomy/laparoscopy) guidance: a new integrated technique for hysterectomized women with vaginal tumors.
    Corn BW, Lanciano RM, Rosenblum N, Schnall M, King S, Epperson R.
    Gynecol Oncol; 1995 Feb 01; 56(2):255-61. PubMed ID: 7896194
    [Abstract] [Full Text] [Related]

  • 20. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.